China Pharma Holdings, Inc.
CPHINYSECIK 1106644HealthcareFiscal year ends Dec 31
Reports and events: 162 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1416:32 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001213900-26-090173 |
| 2026-07-2217:26 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-080475 |
| 2026-05-1516:05 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001213900-26-057705 |
| 2026-04-0116:15 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001213900-26-038521 |
| 2026-03-0316:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-023022 |
| 2026-02-1016:49 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-014338 |
| 2026-01-0616:05 ET | 8-K | 5.07 Shareholder vote results | 0001213900-26-001785 |
| 2025-12-2316:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity | 0001213900-25-125299 |
| 2025-12-1016:49 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity | 0001213900-25-120129 |
| 2025-11-1416:22 ET | DEF 14A | Proxy statementPeriod 2025-12-30 | 0001213900-25-110882 |
| 2025-11-1216:10 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001213900-25-109203 |
| 2025-08-1416:06 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001213900-25-076642 |
| 2025-05-1416:20 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001213900-25-043334 |
| 2025-04-0416:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-029000 |
| 2025-03-3116:20 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001213900-25-026280 |
| 2024-12-2616:30 ET | 8-K | 1.02 Termination of a material agreement | 0001213900-24-112685 |
| 2024-12-2616:05 ET | 8-K | 5.07 Shareholder vote results | 0001213900-24-112658 |
| 2024-12-1308:20 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-24-108617 |
| 2024-11-1316:05 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001213900-24-097461 |
| 2024-11-1216:05 ET | DEF 14A | Proxy statementPeriod 2024-12-22 | 0001213900-24-096780 |
| 2024-08-1416:05 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001213900-24-068984 |
| 2024-05-3016:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-24-047965 |
| 2024-05-1516:06 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001213900-24-043591 |
| 2024-05-0816:05 ET | 8-K | 4.01 Change of auditor | 0001213900-24-040851 |
| 2024-04-0116:06 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001213900-24-028731 |
| 2024-03-2916:05 ET | 8-K | 8.01 Other events | 0001213900-24-027972 |
| 2024-02-2316:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-016507 |
| 2024-02-0816:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity | 0001213900-24-011587 |
| 2023-12-2116:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity | 0001213900-23-097680 |
| 2023-12-1916:05 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0001213900-23-096920 |
| 2023-11-1316:05 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001213900-23-086100 |
| 2023-11-0716:05 ET | DEF 14A | Proxy statementPeriod 2023-12-18 | 0001213900-23-084279 |
| 2023-10-0316:05 ET | 8-K | 3.01 Delisting notice | 0001013762-23-001101 |
| 2023-08-1415:40 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001213900-23-066936 |
| 2023-05-1216:06 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001213900-23-039007 |
| 2023-04-2016:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-23-031309 |
| 2023-03-3016:54 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001213900-23-024710 |
| 2023-03-2916:05 ET | 8-K | 8.01 Other events | 0001213900-23-024081 |
| 2023-02-2416:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-23-014316 |
| 2022-12-3016:05 ET | 8-K | 5.07 Shareholder vote results | 0001213900-22-084016 |
| 2022-12-0217:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-22-077369 |
| 2022-12-0216:10 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001213900-22-077304 |
| 2022-11-1416:58 ET | DEF 14A | Proxy statementPeriod 2022-12-28 | 0001213900-22-072361 |
| 2022-11-1416:09 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001213900-22-072200 |
| 2022-09-3016:15 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001213900-22-060675 |
| 2022-08-1116:05 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001213900-22-046859 |
| 2022-06-2216:05 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001213900-22-034328 |
| 2022-05-1216:06 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001213900-22-025938 |
| 2022-03-3016:06 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001213900-22-016151 |
| 2021-12-2916:00 ET | 8-K | 5.07 Shareholder vote results | 0001213900-21-067912 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:51 ET. Listed shows no prices and gives no investment advice.